|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
218,850,000 |
Market
Cap: |
39.94(B) |
Last
Volume: |
90,505,923 |
Avg
Vol: |
10,707,238 |
52
Week Range: |
$182.5 - $182.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Orloff John J |
EVP, Research & Development |
|
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
40,677 |
85,206 |
|
- |
|
Chiniara Ellen |
EVP & Chief Legal Officer |
|
2020-12-16 |
4 |
D |
$157.96 |
$3,145,457 |
D/D |
(19,913) |
43,004 |
|
- |
|
Chiniara Ellen |
EVP & Chief Legal Officer |
|
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
37,965 |
62,917 |
|
- |
|
Goff Brian |
EVP & Chief Commercial Officer |
|
2020-12-16 |
4 |
D |
$157.96 |
$3,379,554 |
D/D |
(21,395) |
67,301 |
|
- |
|
Goff Brian |
EVP & Chief Commercial Officer |
|
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
40,677 |
88,696 |
|
- |
|
Bazarko Daniel |
SVP, Controller, CAO |
|
2020-12-16 |
4 |
D |
$157.96 |
$1,391,944 |
D/D |
(8,812) |
30,883 |
|
- |
|
Bazarko Daniel |
SVP, Controller, CAO |
|
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,371 |
39,695 |
|
- |
|
Hantson Ludwig |
CEO |
|
2020-12-16 |
4 |
D |
$157.96 |
$13,520,112 |
D/D |
(85,592) |
267,773 |
|
- |
|
Hantson Ludwig |
CEO |
|
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
162,707 |
353,365 |
|
- |
|
Franchini Indrani Lall |
EVP, Chief Compliance Officer |
|
2020-12-16 |
4 |
D |
$157.96 |
$3,133,610 |
D/D |
(19,838) |
46,345 |
|
- |
|
Franchini Indrani Lall |
EVP, Chief Compliance Officer |
|
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
37,965 |
66,183 |
|
- |
|
Orloff John J |
EVP, Research & Development |
|
2020-12-15 |
4 |
A |
$93.53 |
$3,741 |
D/D |
40 |
63,851 |
|
- |
|
Chiniara Ellen |
EVP & Chief Legal Officer |
|
2020-12-15 |
4 |
A |
$95.53 |
$5,350 |
D/D |
56 |
43,060 |
|
- |
|
Sarin Aradhana |
EVP, CFO |
|
2020-11-30 |
4 |
D |
$124.00 |
$160,952 |
D/D |
(1,298) |
33,459 |
|
- |
|
Law Anne-Marie |
EVP, Chief Experience Officer |
|
2020-06-08 |
4 |
D |
$114.61 |
$293,516 |
D/D |
(2,561) |
41,423 |
|
- |
|
Orloff John J |
EVP, Research & Development |
|
2020-06-08 |
4 |
D |
$114.61 |
$319,074 |
D/D |
(2,784) |
44,529 |
|
- |
|
Franchini Indrani Lall |
EVP, Chief Compliance Officer |
|
2020-06-08 |
4 |
AS |
$114.61 |
$785,981 |
D/D |
(6,853) |
28,218 |
|
2% |
|
Franchini Indrani Lall |
EVP, Chief Compliance Officer |
|
2020-06-08 |
4 |
D |
$114.61 |
$160,798 |
D/D |
(1,403) |
35,071 |
|
- |
|
Goff Brian |
EVP & Chief Commercial Officer |
|
2020-06-08 |
4 |
D |
$114.61 |
$188,190 |
D/D |
(1,642) |
48,019 |
|
- |
|
Dunsire Deborah |
Director |
|
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,409 |
12,134 |
|
- |
|
Baker Julian |
Director |
|
2020-05-14 |
4 |
A |
$0.00 |
$0 |
I/I |
9,314 |
7,846,213 |
|
- |
|
Mollen John T |
Director |
|
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,468 |
12,701 |
|
- |
|
Nader Francois |
Director |
|
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
4,409 |
11,286 |
|
- |
|
Brennan David R |
Director |
|
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,896 |
17,537 |
|
- |
|
Friedman Paul A |
Director |
|
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,468 |
10,345 |
|
- |
|
609 Records found
|
|
Page 3 of 25 |
|
|